An inverse correlation of VZV skin-test reaction, but not antibody, with severity of herpes zoster skin symptoms and zoster-associated pain

Journal of Dermatological Science

Volumn 69, Issue 3, 2013, Pages 243-249

  Asada, Hideo ^a   Nagayama, Kousuke ^a   Okazaki, Aiko ^a   Mori, Yasuko ^b,c   Okuno, Yoshinobu ^d   Takao, Yukiko ^d   Miyazaki, Yoshiyuki ^d   Onishi, Fumitake ^d   Okeda, Masayuki ^d   Yano, Shuichiro ^d   Kumihashi, Hideaki ^d   Gomi, Yasuyuki ^d   Maeda, Kazuhiro ^d   Ishikawa, Toyokazu ^d   Iso, Hiroyasu ^e   Yamanishi, Koichi ^c  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION   (Japan)

^d The Research Foundation for Microbial Diseases of Osaka University   (Japan)

^e OSAKA UNIVERSITY   (Japan)

Author keywords

Cell mediated immunity; Cohort study; Herpes zoster; Humoral immunity; VZV skin test

Indexed keywords

VIRUS ANTIBODY;

ADULT; AGED; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; CELLULAR IMMUNITY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HERPES ZOSTER; HUMAN; IMMUNE ADHERENCE; IMMUNOREGULATION; INTRACUTANEOUS TEST; JAPAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SKIN DEFECT; SKIN MANIFESTATION; SKIN PAIN; VIRUS IMMUNITY; VIRUS NEUTRALIZATION;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIBODIES; FEMALE; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; JAPAN; MALE; MIDDLE AGED; NEURALGIA, POSTHERPETIC; PAIN; PROSPECTIVE STUDIES; SEX FACTORS; SKIN TESTS; TIME FACTORS;

EID: 84875247715     PISSN: 09231811     EISSN: 1873569X     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2012.10.015     Document Type: Article

References (24)

1. Grose C. Variation on a theme by Fenner: the pathogenesis of chickenpox. Pediatrics 1981, 68:735-737.
2. Ku C.C., Besser J., Abendroth A., Grose C., Arvin A.M. Varicella-Zoster virus pathogenesis and immunobiology: new concepts emerging from investigations with the SCIDhu mouse model. J Virol 2005, 79:2651-2658.
3. Mims C., White D. Viral pathogenesis and immunology 1984, Blackwell Scientific Publications, Oxford.
4. Oxman M.N., Levin M.J., Johnson G.R., Schmader K.E., Straus S.E., Gelb L.D., et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005, 352:2271-2284.
5. Harpaz R., Ortega-Sanchez I.R., Seward J.F. Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2008, 57:1-30. [quiz CE32-34].
6. Weinberg A., Zhang J.H., Oxman M.N., Johnson G.R., Hayward A.R., Caulfield M.J., et al. Varicella-zoster virus-specific immune responses to herpes zoster in elderly participants in a trial of a clinically effective zoster vaccine. J Infect Dis 2009, 200:1068-1077.
7. Takao Y., Miyazaki Y., Onishi F., Kumihashi H., Gomi Y., Ishikawa T., et al. The Shozu Herpes Zoster (SHEZ) study: rationale, design, and description of a prospective cohort study. J Epidemiol 2012, 22:167-174. [Epub 2012].
8. Kamiya H., Ihara T., Hattori A., Iwasa T., Sakurai M., Izawa T., et al. Diagnostic skin test reactions with varicella virus antigen and clinical application of the test. J Infect Dis 1977, 136:784-788.
9. Asano Y., Shiraki K., Takahashi M., Nagai H., Ozaki T., Yazaki T. Soluble skin test antigen of varicella-zoster virus prepared from the fluid of infected cultures. J Infect Dis 1981, 143:684-692.
10. Takahashi M., Okada S., Miyagawa H., Amo K., Yoshikawa K., Asada H., et al. Enhancement of immunity against VZV by giving live varicella vaccine to the elderly assessed by VZV skin test and IAHA, gpELISA antibody assay. Vaccine 2003, 21:3845-3853.
11. Sadaoka K., Okamoto S., Gomi Y., Tanimoto T., Ishikawa T., Yoshikawa T., et al. Measurement of varicella-zoster virus (VZV)-specific cell-mediated immunity: comparison between VZV skin test and interferon-gamma enzyme-linked immunospot assay. J Infect Dis 2008, 198:1327-1333.
12. Provost P.J., Krah D.L., Kuter B.J., Morton D.H., Schofield T.L., Wasmuth E.H., et al. Antibody assays suitable for assessing immune responses to live varicella vaccine. Vaccine 1991, 9:111-116.
13. Gershon A.A., Kalter Z.G., Steinberg S., Kuhns W.J. Detection of antibody to Varicella-Zoster virus by immune adherence hemagglutination. Proc Soc Exp Biol Med 1976, 151:762-765.
14. Kalter Z.G., Steinberg S., Gershon A.A. Immune adherence hemagglutination: further observations on demonstration of antibody to varicella-zoster virus. J Infect Dis 1977, 135:1010-1013.
15. Yamada A., Ogino S., Asano Y., Otsuka T., Takahashi M., Baba K., et al. Comparison of 4 serological tests - complement fixation, neutralization, fluorescent antibody to membrane antigen and immune adherence hemagglutination - for assay of antibody to varicella-zoster (V-Z) virus. Biken J 1979, 22:55-60.
16. Coplan P.M., Schmader K., Nikas A., Chan I.S., Choo P., Levin M.J., et al. Development of a measure of the burden of pain due to herpes zoster and postherpetic neuralgia for prevention trials: adaptation of the brief pain inventory. J Pain 2004, 5:344-356.
17. Berger R., Florent G., Just M. Decrease of the lymphoproliferative response to varicella-zoster virus antigen in the aged. Infect Immun 1981, 32:24-27.
18. Levin M.J., Oxman M.N., Zhang J.H., Johnson G.R., Stanley H., Hayward A.R., et al. Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine. J Infect Dis 2008, 197:825-835.
19. Levin M.J., Murray M., Rotbart H.A., Zerbe G.O., White C.J., Hayward A.R. Immune response of elderly individuals to a live attenuated varicella vaccine. J Infect Dis 1992, 166:253-259.
20. Levin M.J., Smith J.G., Kaufhold R.M., Barber D., Hayward A.R., Chan C.Y., et al. Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a high-dose VZV vaccine. J Infect Dis 2003, 188:1336-1344.
21. Hope-Simpson R.E. Postherpetic neuralgia. J R Coll Gen Pract 1975, 25:571-575.
22. Ragozzino M.W., Melton L.J., Kurland L.T., Chu C.P., Perry H.O. Population-based study of herpes zoster and its sequelae. Medicine (Baltimore) 1982, 61:310-316.
23. Opstelten W., Mauritz J.W., de Wit N.J., van Wijck A.J., Stalman W.A., van Essen G.A. Herpes zoster and postherpetic neuralgia: incidence and risk indicators using a general practice research database. Fam Pract 2002, 19:471-475.
24. Trannoy E., Berger R., Hollander G., Bailleux F., Heimendinger P., Vuillier D., et al. Vaccination of immunocompetent elderly subjects with a live attenuated Oka strain of varicella zoster virus: a randomized, controlled, dose-response trial. Vaccine 2000, 18:1700-1706.